MOR MorphoSys Corp Yalpi foyda marjasi

MOR (MorphoSys Corporation) - kompaniyaning tovar belgisi

Holdingning sotib olish va dastur integratsiyasi yakunlanganidan so'ng, GURU.Markets dagi tahliliy grafikda yalpi foyda ko'rsatkichi keltirilgan bo'lib, bunda 75.90 ushbu parametr darajasini belgilaydi. MorphoSys AG (MOR) R&D poygasida o'zining patent portfeliga va pelabresib sinovlariga tayanadi. AQSh va Germaniyadagi laboratoriyalar onkologik terapiyalarni ishlab chiqmoqda, ularning barqarorligi esa global yetakchining sho'ba korxonasi maqomi bilan kafolatlanadi.

MOR MorphoSys Corp Yalpi foyda bo'yicha rentabellik (04.07.2022 - 10.08.2024)

MorphoSys AG (MOR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:MorphoSys AG
MorphoSys Corporation seriyali mahsuloti

O'z onkologiya ishlanmalarini sog'liqni saqlash giganti tuzilmasiga integratsiya qilayotgan MorphoSys AG (MOR) uchun yalpi foyda marjasi bevosita xarajatlarni boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika tushumdan sotilgan tovarlar tannarxini ayirish orqali hisoblanadi va biznesning operatsion xarajatlar hisobga olinishidan oldin foyda keltirish qobiliyatini namoyish etadi. Jori yalpi foyda marjasi darajasini tahlil qilish orqali investor aktivlarning birlashishi fonida dori ishlab chiqarish xarajatlaridagi anomaliyalarni aniqlashi mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|CKPT: Yalpi marja|Elevation Oncology - Yalpi foyda normasi|ICAD (iCAD) - Yalpi marja|IKNA: Yalpi foyda normasi|Yalpi rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Yalpi foyda normasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik